Teva blinks again

Three months after President and CEO Jeremy Levin's ouster from Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) shocked and disappointed investors, Chairman Phillip Frost appears to be extending an olive branch.

In a letter to shareholders last week, Frost said Teva plans to add new board members with global healthcare experience while reducing the board's size. In addition, the company reported at the JPMorgan Healthcare Conference this month that incoming CEO Erez Vigodman will retain his seat on the board - a first for the Israeli company...